Improved cancer therapy based on tumor associated antigens derived from cyclin D1

Details for Australian Patent Application No. 2011260277 (hide)

Owner immatics biotechnologies GmbH

Inventors Singh, Harpreet; Weinschenk, Toni; Walter, Steffen

Agent Pizzeys

Pub. Number AU-A-2011260277

PCT Pub. Number WO2011/151403

Priority 1009222.9 02.06.10 GB; 61/350,731 02.06.10 US

Filing date 1 June 2011

Wipo publication date 8 December 2011

International Classifications

C07K 14/47 Peptides having more than 20 amino acids

A61K 38/04 Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 Antineoplastic agents

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/151403 Priority application(s): WO2011/151403

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011260447-Apparatus and method for severing fillets completely from the carcass of beheaded and eviscerated fish, a crosspiece left by other tools being cut through in the process

2011259844-Agents and Methods Related to Reducing Resistance to Apoptosisinducing Death Receptor Agonists